Q32 Bio Inc. (QTTB) Operating margin 2018–2025
Q32 Bio Inc. (QTTB) operating margin by fiscal year — reported operating income divided by reported revenue.
31.5%FY2025 · since FY2018: -1126.0% → 31.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 31.5% | — |
| FY2023 | -4174.3% | -19.7 pp |
| FY2022 | -4154.6% | -3872.2 pp |
| FY2021 | -282.4% | +4538.5 pp |
| FY2020 | -4821.0% | +1778.2 pp |
| FY2019 | -6599.2% | -5473.2 pp |
| FY2018 | -1126.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More QTTB financial trends
QTTB RevenueQTTB Net incomeQTTB Net marginQTTB Gross profitQTTB Gross marginQTTB Operating incomeQTTB Operating cash flowQTTB Free cash flowQTTB Capital expendituresQTTB Return on equityQTTB Stock buybacksQTTB Dividends paidQTTB Total assetsQTTB Total liabilitiesQTTB Shareholders’ equityQTTB overview →